| scholarly article | Q13442814 |
| P50 | author | Imran Mohammed | Q51214011 |
| P2093 | author name string | Leonardo Mastropasqua | |
| Mario Nubile | |||
| Harminder S Dua | |||
| Dalia G Said | |||
| P2860 | cites work | Decoding the Functional Roles of Cationic Side Chains of the Major Antimicrobial Region of Human Cathelicidin LL-37 | Q27675567 |
| High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments | Q27692605 | ||
| Optimizing the Clinical Use of Vancomycin | Q28069334 | ||
| Responses of Pseudomonas aeruginosa to antimicrobials | Q28305587 | ||
| Novel engineered cationic antimicrobial peptides display broad-spectrum activity against Francisella tularensis, Yersinia pestis and Burkholderia pseudomallei. | Q30382544 | ||
| Cytotoxic clinical isolates of Pseudomonas aeruginosa identified during the Steroids for Corneal Ulcers Trial show elevated resistance to fluoroquinolones | Q33559958 | ||
| Cathelicidin host defence peptide augments clearance of pulmonary Pseudomonas aeruginosa infection by its influence on neutrophil function in vivo | Q33700171 | ||
| Antibiotic resistance-the need for global solutions | Q34386251 | ||
| Cathelicidin-deficient (Cnlp -/- ) mice show increased susceptibility to Pseudomonas aeruginosa keratitis | Q34522531 | ||
| Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes | Q34552966 | ||
| FK-16 derived from the anticancer peptide LL-37 induces caspase-independent apoptosis and autophagic cell death in colon cancer cells. | Q34735130 | ||
| Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances | Q34750112 | ||
| A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs | Q34758093 | ||
| Pseudomonas aeruginosa: resistance to the max | Q35084559 | ||
| The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit | Q35794409 | ||
| Bacterial infections of the cornea (Pseudomonas aeruginosa). | Q36722835 | ||
| Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections. | Q36740138 | ||
| The antimicrobial resistance containment and surveillance approach--a public health tool | Q37055644 | ||
| Association between cytotoxic and invasive Pseudomonas aeruginosa and clinical outcomes in bacterial keratitis | Q37228376 | ||
| Review of resistance of ocular isolates of Pseudomonas aeruginosa and staphylococci from keratitis to ciprofloxacin, gentamicin and cephalosporins. | Q37810333 | ||
| Multidrug-Resistant Pseudomonas aeruginosa Keratitis: Risk Factors, Clinical Characteristics, and Outcomes | Q38550094 | ||
| Surgical management of corneal infections | Q38812691 | ||
| Esculentin-1a(1-21)NH2: a frog skin-derived peptide for microbial keratitis | Q39149551 | ||
| Human antimicrobial peptides in ocular surface defense. | Q39355040 | ||
| Increased susceptibility of Pseudomonas aeruginosa to ciprofloxacin in the presence of vancomycin | Q39882590 | ||
| Outcomes of Infectious versus Sterile Perforated Corneal Ulcers after Therapeutic Penetrating Keratoplasty in the United States | Q39924784 | ||
| Titanium surfaces immobilized with the major antimicrobial fragment FK-16 of human cathelicidin LL-37 are potent against multiple antibiotic-resistant bacteria | Q40148057 | ||
| The Naturally Occurring Host Defense Peptide, LL-37, and Its Truncated Mimetics KE-18 and KR-12 Have Selected Biocidal and Antibiofilm Activities Against Candida albicans, Staphylococcus aureus, and Escherichia coli In vitro. | Q40251230 | ||
| Glycopeptide Antibiotic To Overcome the Intrinsic Resistance of Gram-Negative Bacteria. | Q40541296 | ||
| Intracellular activity of a membrane-active glycopeptide antibiotic against meticillin-resistant Staphylococcus aureus infection | Q40606977 | ||
| Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible modes of action | Q41456132 | ||
| Update on the Management of Infectious Keratitis | Q41931288 | ||
| Synthetic Peptides to Target Stringent Response-Controlled Virulence in a Pseudomonas aeruginosa Murine Cutaneous Infection Model | Q41986754 | ||
| Structural location determines functional roles of the basic amino acids of KR-12, the smallest antimicrobial peptide from human cathelicidin LL-37. | Q42053270 | ||
| Profile of sight-threatening infectious keratitis: a prospective study | Q43671905 | ||
| Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones | Q44328530 | ||
| Arginine-lysine positional swap of the LL-37 peptides reveals evolutional advantages of the native sequence and leads to bacterial probes | Q46375567 | ||
| Colistin causes profound morphological alteration but minimal cytoplasmic membrane perforation in populations of Escherichia coli and Pseudomonas aeruginosa. | Q50052264 | ||
| LL-37-derived membrane-active FK-13 analogs possessing cell selectivity, anti-biofilm activity and synergy with chloramphenicol and anti-inflammatory activity | Q50208808 | ||
| Antibiotic Use in Agriculture and Its Consequential Resistance in Environmental Sources: Potential Public Health Implications. | Q52337071 | ||
| Activity of antimicrobial peptides and conventional antibiotics against superantigen positive Staphylococcus aureus isolated from patients with atopic dermatitis. | Q53700112 | ||
| Rational design and synthesis of modified teixobactin analogues: in vitro antibacterial activity against Staphylococcus aureus, Propionibacterium acnes and Pseudomonas aeruginosa. | Q54217425 | ||
| Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region. | Q54466322 | ||
| Cathelicidin-Derived Antimicrobial Peptides Inhibit Zika Virus Through Direct Inactivation and Interferon Pathway. | Q54558551 | ||
| The spectrum of antimicrobial peptide expression at the ocular surface. | Q54673989 | ||
| Antimicrobial Peptides: Interaction With Model and Biological Membranes and Synergism With Chemical Antibiotics. | Q55252918 | ||
| Synergy between conventional antibiotics and anti-biofilm peptides in a murine, sub-cutaneous abscess model caused by recalcitrant ESKAPE pathogens. | Q55432018 | ||
| Characterization of host responses during acute lung infection in the lungs and blood and after treatment with the synthetic immunomodulatory peptide IDR-1002 | Q57462992 | ||
| Antimicrobial peptide LL-37 and its truncated forms, GI-20 and GF-17, exert spermicidal effects and microbicidal activity against Neisseria gonorrhoeae | Q57791643 | ||
| Antimicrobial resistance and the role of vaccines | Q60301815 | ||
| Reassessing the Host Defense Peptide Landscape | Q61799995 | ||
| The ‘up–down’ sign of acute ocular surface drug toxicity | Q61824876 | ||
| Successful treatment of multidrug-resistant Pseudomonas aeruginosa meningitis with intravenous and intrathecal colistin | Q81428554 | ||
| Multifunctional roles of human cathelicidin (LL-37) at the ocular surface | Q83839600 | ||
| Antimicrobial Activity of Selected Antimicrobial Peptides Against Planktonic Culture and Biofilm of Acinetobacter baumannii | Q90458028 | ||
| Antibiotic Resistance Rates by Geographic Region Among Ocular Pathogens Collected During the ARMOR Surveillance Study | Q90864213 | ||
| Development of a Broad-Spectrum Antimicrobial Combination for the Treatment of Staphylococcus aureus and Pseudomonas aeruginosa Corneal Infections | Q93015814 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | Pseudomonas aeruginosa | Q31856 |
| vancomycin | Q424027 | ||
| P304 | page(s) | 2190 | |
| P577 | publication date | 2019-09-19 | |
| P1433 | published in | Frontiers in Microbiology | Q27723481 |
| P1476 | title | Cathelicidin-Derived Synthetic Peptide Improves Therapeutic Potential of Vancomycin Against Pseudomonas aeruginosa | |
| P478 | volume | 10 |
| Q104795267 | Infectious keratitis: an update on epidemiology, causative microorganisms, risk factors, and antimicrobial resistance |
| Q96303599 | Strategies in Translating the Therapeutic Potentials of Host Defense Peptides |
Search more.